16 results on '"Hong, Huiqi"'
Search Results
2. SIRT3 prevents angiotensin II-induced renal tubular epithelial-mesenchymal transition by ameliorating oxidative stress and mitochondrial dysfunction
- Author
-
He, Ping, Li, Zhuoming, Yue, Zhongbao, Gao, Hui, Feng, Guoshuai, Wang, Panxia, Huang, Yi, Luo, Wenwei, Hong, Huiqi, Liang, Liying, Chen, Shaorui, and Liu, Peiqing
- Published
- 2018
- Full Text
- View/download PDF
3. Protocatechuic aldehyde protects against isoproterenol-induced cardiac hypertrophy via inhibition of the JAK2/STAT3 signaling pathway
- Author
-
Fang, Xiuli, Liu, Yajun, Lu, Jing, Hong, Huiqi, Yuan, Jing, Zhang, Yuhong, Wang, Panxia, Liu, Peiqing, and Ye, Jiantao
- Published
- 2018
- Full Text
- View/download PDF
4. Author Correction: Systematic evaluation and optimization of the experimental steps in RNA G-quadruplex structure sequencing
- Author
-
Yeung, Pui Yan, Zhao, Jieyu, Chow, Eugene Yui-Ching, Mou, Xi, Hong, HuiQi, Chen, Leilei, Chan, Ting-Fung, and Kwok, Chun Kit
- Published
- 2020
- Full Text
- View/download PDF
5. Cis- and trans-regulations of pre-mRNA splicing by RNA editing enzymes influence cancer development
- Author
-
Tang, Sze Jing, Shen, Haoqing, An, Omer, Hong, HuiQi, Li, Jia, Song, Yangyang, Han, Jian, Tay, Daryl Jin Tai, Ng, Vanessa Hui En, Bellido Molias, Fernando, Leong, Ka Wai, Pitcheshwar, Priyankaa, Yang, Henry, and Chen, Leilei
- Published
- 2020
- Full Text
- View/download PDF
6. SIRT6 suppresses isoproterenol-induced cardiac hypertrophy through activation of autophagy
- Author
-
Lu, Jing, Sun, Duanping, Liu, Zhiping, Li, Min, Hong, Huiqi, Liu, Cui, Gao, Si, Li, Hong, Cai, Yi, Chen, Shaorui, Li, Zhuoming, Ye, Jiantao, and Liu, Peiqing
- Published
- 2016
- Full Text
- View/download PDF
7. Systematic evaluation and optimization of the experimental steps in RNA G-quadruplex structure sequencing
- Author
-
Yeung, Pui Yan, Zhao, Jieyu, Chow, Eugene Yui-Ching, Mou, Xi, Hong, HuiQi, Chen, Leilei, Chan, Ting-Fung, and Kwok, Chun Kit
- Published
- 2019
- Full Text
- View/download PDF
8. MicroRNA-34c-5p provokes isoprenaline-induced cardiac hypertrophy by modulating autophagy via targeting ATG4B.
- Author
-
Zhang, Yuhong, Ding, Yanqing, Li, Min, Yuan, Jing, Yu, Youhui, Bi, Xueying, Hong, Huiqi, Ye, Jiantao, and Liu, Peiqing
- Subjects
CARDIAC hypertrophy ,ATRIAL natriuretic peptides ,AUTOPHAGY ,HEART diseases ,INTRAVENOUS injections ,CONTRACTILE proteins - Abstract
Pathological cardiac hypertrophy serves as a significant foundation for cardiac dysfunction and heart failure. Recently, growing evidence has revealed that microRNAs (miRNAs) play multiple roles in biological processes and participate in cardiovascular diseases. In the present research, we investigate the impact of miRNA-34c-5p on cardiac hypertrophy and the mechanism involved. The expression of miR-34c-5p was proved to be elevated in heart tissues from isoprenaline (ISO)-infused mice. ISO also promoted miR-34c-5p level in primary cultures of neonatal rat cardiomyocytes (NRCMs). Transfection with miR-34c-5p mimic enhanced cell surface area and expression levels of foetal-type genes atrial natriuretic factor (Anf) and β -myosin heavy chain (β-Mhc) in NRCMs. In contrast, treatment with miR-34c-5p inhibitor attenuated ISO-induced hypertrophic responses. Enforced expression of miR-34c-5p by tail intravenous injection of its agomir led to cardiac dysfunction and hypertrophy in mice, whereas inhibiting miR-34c-5p by specific antagomir could protect the animals against ISO-triggered hypertrophic abnormalities. Mechanistically, miR-34c-5p suppressed autophagic flux in cardiomyocytes, which contributed to the development of hypertrophy. Furthermore, the autophagy-related gene 4B (ATG4B) was identified as a direct target of miR-34c-5p, and miR-34c-5p was certified to interact with 3′ untranslated region of Atg4b mRNA by dual-luciferase reporter assay. miR-34c-5p reduced the expression of ATG4B, thereby resulting in decreased autophagy activity and induction of hypertrophy. Inhibition of miR-34c-5p abolished the detrimental effects of ISO by restoring ATG4B and increasing autophagy. In conclusion, our findings illuminate that miR-34c-5p participates in ISO-induced cardiac hypertrophy, at least partly through suppressing ATG4B and autophagy. It suggests that regulation of miR-34c-5p may offer a new way for handling hypertrophy-related cardiac dysfunction. Isoprenaline promotes miR-34c-5p expression in cardiomyocytes, which inhibits autophagy by targeting ATG4B. The miR-34c-5p/ATG4B axis might be an important pathway contributing to the development of cardiac hypertrophy. [Display omitted] [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
9. Chrysophanol attenuated isoproterenol‐induced cardiac hypertrophy by inhibiting Janus kinase 2/signal transducer and activator of transcription 3 signaling pathway.
- Author
-
Yuan, Jing, Hong, Huiqi, Zhang, Yuhong, Lu, Jing, Yu, Youhui, Bi, Xueying, Wang, Junjian, and Ye, Jiantao
- Subjects
- *
CARDIAC hypertrophy , *ISOPROTERENOL , *JANUS kinases , *JAK-STAT pathway , *CELL membranes - Abstract
Cardiac hypertrophy is a common pathological change found in various cardiovascular diseases. Although it has long been recognized as an important risk factor responsible for heart failure, there is still a lack of effective treatments in clinic. Chrysophanol is a natural compound with multiple biological activities and protective roles in the cardiovascular system. However, its potential effect on cardiac hypertrophy remains unclear. In the current study, we found that chrysophanol could protect against isoproterenol (ISO)‐induced cardiac hypertrophy both in vitro and in vivo. Increase of cell surface and hypertrophic marker expression induced by ISO in neonatal rat cardiomyocytes was downregulated by chrysophanol. Moreover, chrysophanol ameliorated the abnormal changes of cardiac structure and function in rats subjected to ISO injection, as shown by echocardiography and morphometry measurements. Further mechanistical investigation demonstrated that chrysophanol inhibited phosphorylation of Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) induced by ISO. Nuclear translocation of STAT3 and transcription of downstream genes promoted by ISO treatment were also remarkably suppressed by chrysophanol. Taken together, our findings revealed that chrysophanol attenuated ISO‐induced cardiac hypertrophy by inhibiting JAK2/STAT3 signaling pathway. Chrysophanol may be a potential candidate compound for the prevention and treatment of hypertrophy‐related cardiomyopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
10. Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer.
- Author
-
Hong, HuiQi, An, Omer, Chan, Tim H M, Ng, Vanessa H E, Kwok, Hui Si, Lin, Jaymie S, Qi, Lihua, Han, Jian, Tay, Daryl J T, and Tang, Sze Jing
- Published
- 2018
- Full Text
- View/download PDF
11. ADAR-Mediated RNA Editing Predicts Progression and Prognosis of Gastric Cancer.
- Author
-
Chan, Tim Hon Man, Qamra, Aditi, Tan, Kar Tong, Guo, Jing, Yang, Henry, Qi, Lihua, Lin, Jaymie Siqi, Ng, Vanessa Hui En, Song, Yangyang, Hong, Huiqi, Tay, Su Ting, Liu, Yujing, Lee, Jeeyun, Rha, Sun Yong, Zhu, Feng, So, Jimmy Bok Yan, Teh, Bin Tean, Yeoh, Khay Guan, Rozen, Steve, and Tenen, Daniel G.
- Abstract
Backgroud & Aims Gastric cancer (GC) is the third leading cause of global cancer mortality. Adenosine-to-inosine RNA editing is a recently described novel epigenetic mechanism involving sequence alterations at the RNA but not DNA level, primarily mediated by ADAR (adenosine deaminase that act on RNA) enzymes. Emerging evidence suggests a role for RNA editing and ADARs in cancer, however, the relationship between RNA editing and GC development and progression remains unknown. Methods In this study, we leveraged on the next-generation sequencing transcriptomics to demarcate the GC RNA editing landscape and the role of ADARs in this deadly malignancy. Results Relative to normal gastric tissues, almost all GCs displayed a clear RNA misediting phenotype with ADAR1/2 dysregulation arising from the genomic gain and loss of the ADAR1 and ADAR2 gene in primary GCs, respectively. Clinically, patients with GCs exhibiting ADAR1/2 imbalance demonstrated extremely poor prognoses in multiple independent cohorts. Functionally, we demonstrate in vitro and in vivo that ADAR-mediated RNA misediting is closely associated with GC pathogenesis, with ADAR1 and ADAR2 playing reciprocal oncogenic and tumor suppressive roles through their catalytic deaminase domains, respectively. Using an exemplary target gene PODXL (podocalyxin-like), we demonstrate that the ADAR2-regulated recoding editing at codon 241 (His to Arg) confers a loss-of-function phenotype that neutralizes the tumorigenic ability of the unedited PODXL . Conclusions Our study highlights a major role for RNA editing in GC disease and progression, an observation potentially missed by previous next-generation sequencing analyses of GC focused on DNA alterations alone. Our findings also suggest new GC therapeutic opportunities through ADAR1 enzymatic inhibition or the potential restoration of ADAR2 activity. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
12. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
- Author
-
Lu, Jing, Zhang, Renwei, Hong, Huiqi, Yang, Zuolong, Sun, Duanping, Sun, Shuya, Guo, Xiaolei, Ye, Jiantao, Li, Zhuoming, and Liu, Peiqing
- Subjects
- *
CARDIAC hypertrophy , *ADP-ribosylation , *FORKHEAD transcription factors , *POST-translational modification , *BRAIN natriuretic factor - Abstract
The Forkhead box-containing protein, O subfamily 3 (FoxO3) transcription factor negatively regulates myocardial hypertrophy, and its transcriptional activity is finely conditioned by diverse posttranslational modifications, such as phosphorylation, acetylation, ubiquitination, methylation and glycosylation. Here, we introduce a novel modification of the FoxO3 protein in cardiomyocytes: poly(ADP-ribosyl)ation (PARylation) mediated by poly(ADP-ribose) polymerase-1 (PARP1). This process catalyzes the NAD + -dependent synthesis of polymers of ADP-ribose (PAR) and their subsequent attachment to target proteins by PARPs. Primary-cultured neonatal rat cardiomyocytes were incubated with isoproterenol (ISO) to induce hypertrophy, or were infected with recombinant adenovirus vectors harboring PARP1 cDNA (Ad-PARP1). Sprague-Dawley (SD) rats were treated with ISO to induce cardiac hypertrophy, or were injected with Ad-PARP1 into the anterior and posterior left ventricular walls. Cardiomyocyte surface area, the mRNA expression of hypertrophic biomarkers, echocardiography, morphometry of the hearts were measured. The PARP1 activity was tested by cellular PAR levels. Interactions of PARP1 and FoxO3 were investigated by co-immunoprecipitation and immunofluorescence technique. PARylation of FoxO3 mediated by PARP1 facilitated its phosphorylation at the T32, S252 and S314 sites, triggered its nucleus export and suppressed its transcriptional activity and target genes expression, ultimately inducing cardiac hypertrophy. Additionally, PARP1 silencing or specific inhibition by 3-Aminobenzamide (3AB) and veliparib (ABT-888) alleviated the inhibition of FoxO3 activity by ISO, thus suppressing ISO-induced cardiac hypertrophy. Our data provide the first evidence that PARP1 exacerbates cardiac hypertrophy by PARylation of FoxO3. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
13. RNA editing mediates the functional switch of COPA in a novel mechanism of hepatocarcinogenesis.
- Author
-
Song, Yangyang, An, Omer, Ren, Xi, Chan, Tim Hon Man, Tay, Daryl Jin Tai, Tang, Sze Jing, Han, Jian, Hong, HuiQi, Ng, Vanessa Hui En, Ke, Xinyu, Shen, Haoqing, Pitcheshwar, Priyankaa, Lin, Jaymie Siqi, Leong, Ka Wai, Molias, Fernando Bellido, Yang, Henry, Kappei, Dennis, and Chen, Leilei
- Subjects
- *
RNA editing , *DOUBLE-stranded RNA , *MESSENGER RNA , *DACTINOMYCIN , *NUCLEOTIDE sequence - Abstract
RNA editing introduces nucleotide changes in RNA sequences. Recent studies have reported that aberrant adenosine-to-inosine RNA editing is implicated in cancers. Until now, very few functionally important protein-recoding editing targets have been discovered. Here, we investigated the role of a recently discovered protein-recoding editing target COPA (coatomer subunit α) in hepatocellular carcinoma (HCC). Clinical implication of COPA editing was studied in a cohort of 125 HCC patients. CRISPR/Cas9-mediated knockout of the editing site complementary sequence (ECS) was used to delete edited COPA transcripts endogenously. COPA editing-mediated change in its transcript or protein stability was investigated upon actinomycin D or cycloheximide treatment, respectively. Functional difference in tumourigenesis between wild-type and edited COPA (COPA WT vs. COPA I164V) and the exact mechanisms were also studied in cell models and mice. ADAR2 binds to double-stranded RNA formed between edited exon 6 and the ECS at intron 6 of COPA pre-mRNA, causing an isoleucine-to-valine substitution at residue 164. Reduced editing of COPA is implicated in the pathogenesis of HCC, and more importantly, it may be involved in many cancer types. Upon editing, COPAWT switches from a tumour-promoting gene to a tumour suppressor that has a dominant-negative effect. Moreover, COPAI164V may undergo protein conformational change and therefore become less stable than COPAWT. Mechanistically, COPAI164V may deactivate the PI3K/AKT/mTOR pathway through downregulation of caveolin-1 (CAV1). We uncover an RNA editing-associated mechanism of hepatocarcinogenesis by which downregulation of ADAR2 caused the loss of tumour suppressive COPA I164V and concurrent accumulation of tumour-promoting COPA WT in tumours; a rapid degradation of COPAI164V protein and hyper-activation of the PI3K/AKT/mTOR pathway further promote tumourigenesis. RNA editing is a process in which RNA is changed after it is made from DNA, resulting in an altered gene product. In this study, we found that RNA editing of a gene known as coatomer subunit α (COPA) is lower in tumour samples and discovered that this editing process changes COPA protein from a tumour-promoting form to a tumour-suppressive form. Loss of the edited COPA promotes the development of liver cancer. • Under-editing of COPA is implicated in the pathogenesis of HCC and may be involved in many cancer types. • COPA undergoes an RNA editing-mediated functional switch from a tumour-promoting gene to a tumour suppressor. • COPAI164V represses the PI3K/AKT/mTOR signalling pathway in HCC. • ADAR2 -mediated COPA editing could prevent tumourigenesis by balancing the turnover of COPA as a pool of COPA WT vs. COPA I164V. • When HCC occurs, downregulation of ADAR2 leads to under-editing of COPA , interrupting this balance. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
14. Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression.
- Author
-
Han J, An O, Hong H, Chan THM, Song Y, Shen H, Tang SJ, Lin JS, Ng VHE, Tay DJT, Molias FB, Pitcheshwar P, Tan HQ, Yang H, and Chen L
- Subjects
- Adenosine Deaminase genetics, Adenosine Deaminase metabolism, Humans, Inosine genetics, Inosine metabolism, RNA genetics, Adenosine genetics, Apoptosis Regulatory Proteins metabolism, Neoplasms genetics, Neoplasms metabolism, RNA-Binding Proteins genetics, RNA-Binding Proteins metabolism
- Abstract
RNA editing introduces nucleotide changes in RNA sequences. Recent studies have reported that aberrant A-to-I RNA editing profiles are implicated in cancers. Albeit changes in expression and activity of ADAR genes are thought to have been responsible for the dysregulated RNA editome in diseases, they are not always correlated, indicating the involvement of secondary regulators. Here, we uncover DAP3 as a potent repressor of editing and a strong oncogene in cancer. DAP3 mainly interacts with the deaminase domain of ADAR2 and represses editing via disrupting association of ADAR2 with its target transcripts. PDZD7 , an exemplary DAP3-repressed editing target, undergoes a protein recoding editing at stop codon [Stop →Trp (W)]. Because of editing suppression by DAP3, the unedited PDZD7
WT , which is more tumorigenic than edited PDZD7Stop518W , is accumulated in tumors. In sum, cancer cells may acquire malignant properties for their survival advantage through suppressing RNA editome by DAP3., (Copyright © 2020 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC).)- Published
- 2020
- Full Text
- View/download PDF
15. An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer.
- Author
-
Qi L, Song Y, Chan THM, Yang H, Lin CH, Tay DJT, Hong H, Tang SJ, Tan KT, Huang XX, Lin JS, Ng VHE, Maury JJP, Tenen DG, and Chen L
- Subjects
- 3' Untranslated Regions genetics, Adenosine metabolism, Animals, Gene Expression Regulation, Neoplastic, HEK293 Cells, Humans, Inosine metabolism, Neoplasms metabolism, Tumor Cells, Cultured, Adenosine Deaminase metabolism, Gene Regulatory Networks physiology, Neoplasms genetics, RNA Editing, RNA, Double-Stranded metabolism, RNA-Binding Proteins metabolism
- Abstract
Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by Adenosine DeAminases acting on double-stranded RNA(dsRNA) (ADAR), occurs predominantly in the 3' untranslated regions (3'UTRs) of spliced mRNA. Here we uncover an unanticipated link between ADARs (ADAR1 and ADAR2) and the expression of target genes undergoing extensive 3'UTR editing. Using METTL7A (Methyltransferase Like 7A), a novel tumor suppressor gene with multiple editing sites at its 3'UTR, we demonstrate that its expression could be repressed by ADARs beyond their RNA editing and double-stranded RNA (dsRNA) binding functions. ADARs interact with Dicer to augment the processing of pre-miR-27a to mature miR-27a. Consequently, mature miR-27a targets the METTL7A 3'UTR to repress its expression level. In sum, our study unveils that the extensive 3'UTR editing of METTL7A is merely a footprint of ADAR binding, and there are a subset of target genes that are equivalently regulated by ADAR1 and ADAR2 through their non-canonical RNA editing and dsRNA binding-independent functions, albeit maybe less common. The functional significance of ADARs is much more diverse than previously appreciated and this gene regulatory function of ADARs is most likely to be of high biological importance beyond the best-studied editing function. This non-editing side of ADARs opens another door to target cancer., (© The Author(s) 2017. Published by Oxford University Press on behalf of Nucleic Acids Research.)
- Published
- 2017
- Full Text
- View/download PDF
16. Regulatory factors governing adenosine-to-inosine (A-to-I) RNA editing.
- Author
-
Hong H, Lin JS, and Chen L
- Subjects
- Adenosine genetics, Adenosine Deaminase genetics, Animals, Humans, Inosine genetics, RNA-Binding Proteins genetics, Adenosine metabolism, Adenosine Deaminase metabolism, Inosine metabolism, RNA Editing physiology, RNA-Binding Proteins metabolism
- Abstract
Adenosine-to-inosine (A-to-I) RNA editing, the most prevalent mode of transcript modification in higher eukaryotes, is catalysed by the adenosine deaminases acting on RNA (ADARs). A-to-I editing imposes an additional layer of gene regulation as it dictates various aspects of RNA metabolism, including RNA folding, processing, localization and degradation. Furthermore, editing events in exonic regions contribute to proteome diversity as translational machinery decodes inosine as guanosine. Although it has been demonstrated that dysregulated A-to-I editing contributes to various diseases, the precise regulatory mechanisms governing this critical cellular process have yet to be fully elucidated. However, integration of previous studies revealed that regulation of A-to-I editing is multifaceted, weaving an intricate network of auto- and transregulations, including the involvement of virus-originated factors like adenovirus-associated RNA. Taken together, it is apparent that tipping of any regulatory components will have profound effects on A-to-I editing, which in turn contributes to both normal and aberrant physiological conditions. A complete understanding of this intricate regulatory network may ultimately be translated into new therapeutic strategies against diseases driven by perturbed RNA editing events. Herein, we review the current state of knowledge on the regulatory mechanisms governing A-to-I editing and propose the role of other co-factors that may be involved in this complex regulatory process.
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.